Abstract
Excessive polypharmacy is often associated with inappropriate drug use. Because drug expenditures are heavily skewed and a considerable share of patients in the top 5% of the cost distribution have excessive polypharmacy, the appropriateness of their drug use should be reviewed. The aim of this study was to review the quality of drug use in patients with extremely high costs and excessive polypharmacy and to compare them with all drug users. This is a nationwide register study. The subjects of this study were all drug users in Finland over 15 years of age, n = 3,303,813. The measures used were annual total costs, average costs, and number of patients. The background characteristics used included gender, age, morbidity, number of prescribers, active substances, and indicators of potentially inappropriate drug use, for example, Beers criteria. The patients with high costs and excessive polypharmacy accounted for 22% of the total pharmaceutical expenditures but only 3% of drug users. One-third of them were elderly, compared with 11.3% of all drug users (p < 0.001). Almost all of them, 93.6%, had chronic disease compared with 34.0% of all the drug users (p < 0.001). The high-cost polypharmacy patients used more potentially inapprop...Continue Reading
References
Sep 28, 2001·The Annals of Pharmacotherapy·T JörgensenK Svärdsudd
Jan 16, 2002·JAMA : the Journal of the American Medical Association·David W KaufmanAllen A Mitchell
Jan 8, 2003·PharmacoEconomics·Silvia M EssThomas D Szucs
Apr 10, 2003·Journal of Health Services Research & Policy·Noralou RoosKeumhee Carriere
Jul 16, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lida R Etemad, Joel W Hay
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Daniela FialováUNKNOWN AdHOC Project Research Group
May 21, 2005·The American Journal of Geriatric Pharmacotherapy·Dale ChristensenSteven E Wegner
Aug 13, 2005·Pharmacy World & Science : PWS·Anna Birna Almarsdóttir, Janine M Traulsen
Dec 2, 2006·Research in Social & Administrative Pharmacy : RSAP·Rajender R AparasuHeather Brandt
Jan 11, 2007·Health Affairs·Samuel H Zuvekas, Joel W Cohen
Feb 22, 2007·The Annals of Pharmacotherapy·Elda Jano, Rajender R Aparasu
Jun 15, 2007·European Journal of Clinical Pharmacology·Francesco LandiGraziano Onder
Sep 18, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kristina Johnell, Inga Klarin
Jul 31, 2008·Drugs & Aging·Iain M CareyDerek G Cook
Oct 16, 2008·Journal of Hypertension·Hermann NabiMika Kivimaki
Dec 5, 2008·Journal of the American Geriatrics Society·Syed Imran HaiderJohan Fastbom
Mar 18, 2009·Journal of the American Pharmacists Association : JAPhA·David FoxKristen Foli
Mar 26, 2009·The Annals of Pharmacotherapy·Erin K WelchTroy Stubbings
May 19, 2009·The American Journal of Geriatric Pharmacotherapy·Michael D BuckAdam B Wilcox
Jun 30, 2009·Alzheimer Disease and Associated Disorders·Denys T LauSandra Weintraub
Jul 14, 2009·Drugs & Aging·Johanna JyrkkäSirpa Hartikainen
Aug 25, 2009·Clinical Therapeutics·Hanna KoskinenTimo Maljanen
Dec 8, 2009·Basic & Clinical Pharmacology & Toxicology·Kari FuruHenrik Toft Sørensen
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·V MaioUNKNOWN GAP Investigators
Aug 14, 2010·Medical Care·Jaana E MartikainenArja Helin-Salmivaara
Dec 3, 2010·BMC Clinical Pharmacology·Bo HovstadiusGöran Petersson
Mar 2, 2012·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society 2012 Beers Criteria Update Expert Panel
May 15, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Leena K Saastamoinen, Jouko Verho
May 23, 2012·British Journal of Clinical Pharmacology·Alison BlenkinsoppDavid K Raynor
Dec 1, 2012·Health Policy·Bo Hovstadius, Göran Petersson
Feb 4, 2014·European Journal of Clinical Pharmacology·R A PayneG A Abel
Mar 26, 2014·Research in Social & Administrative Pharmacy : RSAP·A BulajevaM Airaksinen
Citations
Apr 19, 2016·Health Services Research·Deirdre WeymannSteven G Morgan
May 19, 2018·British Journal of Clinical Pharmacology·Heini KariRaisa Laaksonen
Jul 5, 2018·Journal of the American Geriatrics Society·Sonja E KallioMarika K Pohjanoksa-Mäntylä
Jul 14, 2018·Basic & Clinical Pharmacology & Toxicology·Virva HyttinenHannu Valtonen
Nov 6, 2018·Pharmacology Research & Perspectives·Michaela L SchiøtzMikkel B Christensen
Aug 17, 2017·PloS One·Toon van der GrondeToine Pieters
Nov 30, 2019·BMC Geriatrics·Terhi ToivoJuha Puustinen
Nov 23, 2019·BMC Geriatrics·A KiiskiM Pohjanoksa-Mäntylä
Mar 16, 2021·Journal of Alzheimer's Disease : JAD·Frederic GervaisPierre Krolak-Salmon
Jul 22, 2021·BMC Medical Informatics and Decision Making·Caroline SiroisMarc Simard